SCHEMBL12027331

SCHEMBL12027331

COC(=O)c1cc(C)ccc1C#CC1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 1/20 0.43
PTGES O14684 1/20 0.41
NR4A2 P43354 2/20 0.40
GRM5 P41594 1/20 0.40
OPRK1 P41145 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
GAA P10253 1/20 0.36
HCRTR1 O43613 3/20 0.36
HCRTR2 O43614 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
P2RX3 P56373 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544592 0.91 CYP46A1 (0.39) CYP46A1PTGESNR4A2GRM5OPRK1
SCHEMBL2201453 0.84 CYP1A2 (0.48) PTGESNR4A2GAAKDM4EMEN1
SCHEMBL12027328 0.84 CSNK2A1 (0.46) PTGESHCRTR1HCRTR2MEN1KMT2A
Iodomethane SCHEMBL2203367 0.82 CYP1A2 (0.46) PTGESNR4A2GAAKDM4EMEN1
SCHEMBL25544579 0.77 CYP46A1 (0.44) CYP46A1NR4A2TDP1PDK2PDK4
SCHEMBL15357881 0.77 CYP46A1 (0.48) CYP46A1NR4A2TDP1PDK2PDK4
SCHEMBL3178340 0.76 KDM4E (0.44) PTGESNR4A2GAAKDM4EMEN1
SCHEMBL28887682 0.75 LMNA (0.47) CYP46A1NR4A2KDM4EALDH1A1HSP90AA1
SCHEMBL5846153 0.75 GAA (0.51) CYP46A1NR4A2TDP1GAAKDM4E
SCHEMBL21430508 0.74 KDM4E (0.48) GRM5GAAKDM4EKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550761-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-01-24 US disclosed
US-20140080825-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-03-20 US disclosed
US-8541453-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-09-24 US disclosed
US-20110306637-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306637-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CYP46A1 557/4885PTGES 1201/4885NR4A2 867/4885
US-20140080825-A1 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 CYP46A1 557/4885PTGES 1201/4885NR4A2 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.